1.The studies on antihepatitis and anticirrhotic effect of an product from bitter tea (Ilex Kaushue S.Y.Hu) collected in Cao Bang
Journal of Medicinal Materials - Hanoi 2004;9(5):146-151
Product from Bitter tea collected at Cao Bang was studied on antioxidant activities, as well as anti-hepatitis, anti-cirrhosis effects in vivo in the model of cirrhosis mice. Results showed that total saponin extracted from Bitter tea had antitoxic, hepatoprotective, and anti-hepatitis effects, and cirrhosis inhibition
Medicine, Traditional
;
plants, medicinal
;
liver
;
Tea
;
Hepatitis
;
Fibrosis
2.Influence of previous antibiotic use on helicobacter pylori seropositivity in children
Journal of Preventive Medicine 2004;14(4):35-39
At Bach Mai hospital,on 824 pediatric sutbjects aged 6 months – 15 years, the infuence of previously used antibiotics on serological results of the epidemiological diagnosis of Helicobacter pylory infection was evaluated. Among 731 studied children using antibiotics, there was HP (+) in 34,6%. There was no significant relation between the use/no use of antibiotics and HP infected. serological results.There was no same relation between the moment, the frequency,the duration and the antibiotherapy use with the results of serological diagnosis of HP infection
Helicobacter pylori
;
child
;
Anti-Bacterial Agents
3.The value of fine needle aspiration cytopuncture in diagnosis of hepatocellular carcinoma.
Journal of Medical and Pharmaceutical Information 2005;0(12):33-36
In this study, fine needle aspiration cytopuncture (FNAC) was done for 220 patients with liver tumors. The findings showed that FNAC was of high value in diagnosis of Hepatocellular Carcinoma (HCC). Successful first time of FNAC was 93.2%. The accurate rate 97.7%, sensitivity 97.3% and specificity 100%. 19.6% patients were in well differentiated; 47.7% average differentiated and 32.7% poor differentiated. 86.7% tumor under 3cm in diameter with well-differentiation and 86.7% tumor over 9cm in diameter with poor-differentiated. The FNAC is simple, easy performing and safe method
Carcinoma, Hepatocellular, Diagnosis
4.Thymosin-a 1 for treatment of chronic hepatitis B
Journal of Medical and Pharmaceutical Information 2004;0(7):21-24
A study on 56 patients with chronic hepatitis B who were divided into 2 groups: study group and control group. The study group including 31 patients was treated with Thymosin-α1 1.6mg/day, twice a week for 6 months. The control group with 25 patients of same clinical data was treated with common liver-protective drugs. Both groups were monitored and assessed after 24 months. The results showed that the study group with treatment of Thymosin-α1 is better than control one in all aspects of ALT normalization, sero-conversion and decrease of HBV-DNA<5 copies/ml
Hepatitis B, Chronic
;
Therapeutics
5.Clinical and paraclinical features and the factors related to irritable bowel syndrome
Journal of Medical and Pharmaceutical Information 2004;0(9):32-35
A prospective study on 50 patients with irritable bowel syndrome (IBS) at Gastroenterology Department of Central Military Hospital 108 between June 2003 and June 2005. Results showed that the common clinical features of IBS were: abdominal pain (100%), untaste in abdominal cavity (96%), bowel disturbance (100%), flatulence (72%). The relative factors causing IBS consisted of intellectual work (72%), eating much lipid (36%), stinking food (30%) and smoking (16%). The Rome II criteria were applied effectively in the diagnosis of IBS. Three main criteria with very high rates were: 92% pain relieve of bowel movement, 68% pain related to the change of bowel movement frequency and 96% pain related to the change of faeces shape
Irritable Bowel Syndrome
;
Clinical Medicine
6.Clinical, paraclinical pictures and causes of acute pancreatitis
Journal of Medical and Pharmaceutical Information 2005;0(10):33-36
In the study, 166 patients (125 men, 41 women) with acute pancreatitis were treated at Central Military Hospital 108 from August 2003 to August 2005. The common clinical symptoms of acute pancreatitis were epigastrium severe pain 100%, continuous or interrupted pain; localize or spread; fever 51.2%; vomiting 35.5%; abdominal gas 92.8%; peritoneal hypersensitive 92.8%. Among the patients, 90.4% were mild and average; 9.6% were severe. Paraclinical features included a high concentrate of serum and urine amylase (96.4 and 94%, respectively) at different levels that was not relative with the severity; 50% of the patients had big pancreas in ultrasonography. The common causes of acute pancreatitis were big meal with drinking 24.1%, bile stones 13.2%, ascarid in bile tract 9.6% and some other causes; unknown causes 38.7%
Pancreatitis
;
Clinical Medicine
7.Transcatheter Oily Chemoembolization and ? 1-Thymosin in treating HCC
Journal of Medical and Pharmaceutical Information 2003;0(6):31-35
The aim of this study is to evaluate the therapeutic potential of the immunostimulating adjuvant in patients with HCCs¬¬¬.46 patients with HCCs were divided into 2 groups: group I (30pts) treated by Transcatheter Oily Chemoembolization (TOCE alone), group II resulted in a better clinical improvement, decreased AFP and tumor size, and a longer mean survival time versus group I. Combined treatment demonstrated a significant increase in lymphocytes expressing CD 16-CD 56 with NK activity and followed by a rise in lymphocyte with morphological feature of cytotoxic lymphocyte ( CD8 positive) was observed
Liver Neoplasms
;
Thymosin
;
Therapeutics
8.Combination of Transcatheter Oily Chemoembolization and ? 1-Thymosin in treating HCC
Journal of Medical and Pharmaceutical Information 2003;0(6):31-35
The aim of this study is to evaluate the therapeutic potential of the immunostimulating adjuvant in patients with HCCs¬¬¬.46 patients with HCCs were divided into 2 groups: group I (30pts) treated by Transcatheter Oily Chemoembolization (TOCE alone), group II resulted in a better clinical improvement, decreased AFP and tumor size, and a longer mean survival time versus group I. Combined treatment demonstrated a significant increase in lymphocytes expressing CD 16-CD 56 with NK activity and followed by a rise in lymphocyte with morphological feature of cytotoxic lymphocyte ( CD8 positive) was observed
Liver Neoplasms
;
Thymosin
;
Therapeutics
9.Nexium, Ospamox and Klacid (NOK) triple therapy for treatment of gastric ulcer with positive Helicobacter pylori
Journal of Medical and Pharmaceutical Information 2003;0(6):33-36
56 patients with gastric ulcers were treated by triple therapy with Nexium, Ospamox and Klacid (NOK).45 days after treatment, 89.3% patients had no gastric pain; 92.8% patients had ulcer healing, HP eradication rate 94.6% at 6 months and 12 months after treatment, 95% and 93.8% patients had ulcer healing; HP eradication rate was 90% and 90.6%; gastric pain and ulcer recurrence was 7.5% and 6.3%, respectively; HP-positive return rate was 10% and 9.4%
Stomach Ulcer, Helicobacter pylori, Therapeutics
10.Cross-infection of Helicobacter pylori in multiple generation households in Northern Vietnam
Journal of Preventive Medicine 2004;14(5):54-59
Study on prevalence of HP(+) infection and the relationship between HP(+) among children and members in a multi-generation family through 189 children and 344 adults of 99 households. The results showed that, HP seropositivity was 67.4% in adults and 41.3% in children. Some risk factors were identified such as: The seropositive mother was the highest risk factor for HP seropositivity in children and the relationship between HP(+) among children and their mother was independent with other factors. The seropositive father increased HP infective risk in children, but seropostivity in mother was more important. Children's seropositivity was significantly increased in households with 3 children, in those with > 4 persons. No association was found between HP seropositivity in children and that in their grandparents and relatives
Helicobacter pylori
;
Cross Infection
;
Family Characteristics
;
epidemiology